These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2477959)

  • 1. [The effectiveness of barucainide in supraventriculr and ventricular arrhythmias].
    Brugger P
    Z Kardiol; 1989 Aug; 78(8):510-8. PubMed ID: 2477959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of barucainide on left ventricular ejection fraction in patients with ventricular cardiac arrhythmias].
    Scheininger M; Dziersk J; Kullak W; Kors A; Köhler JA; Theisen K
    Z Kardiol; 1991 Oct; 80(10):630-6. PubMed ID: 1722935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dose-dependent anti-arrhythmia effect of retard metoprolol in coronary disease patients with ventricular arrhythmia].
    Hartwig CA; Bethge KP; Wenzlaff P; Lichtlen PR
    Z Kardiol; 1988 Nov; 77(11):704-12. PubMed ID: 2463717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cibenzoline for symptomatic ventricular arrhythmias: a prospective, randomized, double-blind, placebo controlled trial and a long term open label study.
    Lee MA; Fenster PE; Garcia ZM; Kipps JE; Huang SK
    Can J Cardiol; 1989 Sep; 5(6):295-8. PubMed ID: 2477130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pentisomide on stable ventricular premature beats. Comparison with placebo.
    Mangini SG; Mastropasqua F; Oldani V; Massari F; Maino GN; Ricci A; Scrutinio D; Rizzon P
    Eur Heart J; 1991 Jun; 12(6):712-9. PubMed ID: 1713557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suppressive effect of nicorandil in ventricular arrhythmias after reperfusion therapy in patients with acute myocardial infarction].
    Hara H; Horinaka S; Yabe A; Yagi H; Tsuboko Y; Yoshida K; Iemura T; Matsuoka H
    J Cardiol; 2007 Mar; 49(3):135-41. PubMed ID: 17444139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spontaneous variability of ventricular arrhythmias in follow-up of anti-arrhythmia therapy].
    Schmidt G; Barthel P; Ulm K; Goedel-Meinen L; Baedeker W
    Herz; 1990 Feb; 15(1):11-20. PubMed ID: 1690167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].
    Dumoulin P; Jaillon P; Kher A; Poirier JM; Cheymol G; Valty J; Flammang D; Coumel P; Medvedowsky JL; Barnay C
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():105-9. PubMed ID: 2420299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of ventricular arrhythmias with propafenone].
    Petri H; Kafka W; Rudolph W
    Herz; 1985 Feb; 10(1):44-52. PubMed ID: 2579879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW; Nayebagha A; Fabry E
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic effectiveness of creatinol O-phosphate in man.
    Cadel A; Palumbo A; Zerilli G; Pria R; Fanciulli R; Conversano S; Galbiati R
    Arzneimittelforschung; 1979; 29(9a):1485-7. PubMed ID: 94266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose caffeine and ventricular arrhythmias.
    Myers MG; Harris L
    Can J Cardiol; 1990 Apr; 6(3):95-8. PubMed ID: 1692755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term variability in unsustained ventricular arrhythmias: pharmacologic and pro-arrhythmic effect].
    Gaita F; Richiardi E; Bobbio M; Chiotti D; Brusca A
    G Ital Cardiol; 1989 Oct; 19(10):908-12. PubMed ID: 2482213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.